Key result
Higher Life's Crucial 9 score linked to ~31% lower metabolic syndrome prevalence per 10-point increase.
Why the study?
The exact nature of the relationship among cardiovascular system health status, obesity, and metabolic syndrome has not yet been established.
Does a higher Life's Crucial 9 score reduce the prevalence of Metabolic Syndrome in US adults?
Cross-Sectional (n=25,399)
Yes
Does a higher Life's Crucial 9 score reduce the prevalence of Metabolic Syndrome in US adults?
Higher cardiovascular health as measured by Life's Crucial 9 is significantly associated with a lower prevalence of metabolic syndrome, with the weight-adjusted waist index mediating approximately one-third of this relationship.
Answers are grounded in this paper and cite their sources.
Higher Life's Crucial 9 scores were associated with lower metabolic syndrome prevalence; leaves open causality and clinical utility pending prospective trials.
Research has shown that the health status of the cardiovascular system and obesity may be associated with Metabolic Syndrome (MetS) to some extent. However, the exact nature of the relationship between the three has not yet been established. Life’s Crucial 9 (LC9) represents a contemporary metric for comprehensive cardiovascular health evaluation. Separately, the Weight-Adjusted Waist Index (WWI) serves as an emerging anthropometric indicator that differs fundamentally from BMI by normalizing waist circumference through weight standardization, leading to its growing adoption in current research. This study sought to elucidate the association between LC9 and MetS and to evaluate the potential role of WWI in the association. This investigation drew upon data from the National Health and Nutrition Examination Survey (NHANES) to conduct a cross-sectional analysis. The association between LC9 and MetS was assessed through multiple analytical techniques, employing multivariate logistic regression, restricted cubic splines (RCS), and subgroup stratification. Furthermore, mediation modeling was implemented to quantify the extent to which WWI might account for the observed relationship. This study included 25,399 participants, among whom 7,811 reported MetS events. After adjusting for all variables using multivariate logistic regression, each 10-unit increase in LC9 was associated with a 31% reduction in the prevalence of MetS (OR = 0.69, 95% CI: 0.66 to 0.72), while each 1-unit increase in WWI was associated with a 1.11-fold increase in the prevalence of MetS (OR = 2.11, 95% CI: 1.94 to 2.29). Consistent results were observed when LC9 and WWI were adjusted to tertiles, with P for trend < 0.001. Analysis using RCS indicated a linear negative correlation between LC9 and the prevalence of MetS. Mediation analysis indicated that WWI statistically accounted for 32.73% of the observed association between LC9 and MetS ( p < 0.001). This study demonstrates a significant inverse association between LC9 and MetS, with WWI statistically accounting for a substantial portion of this association. These results highlight the interplay between cardiovascular health metrics and metabolic disorders, thereby suggesting that favorable body composition profiles are associated with lower MetS prevalence in the context of higher cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cross-sectional in Metabolic Syndrome (n=25,399). Life's Crucial 9 (LC9) vs. Lower LC9 scores was evaluated on Prevalence of Metabolic Syndrome (OR 0.69, 95% CI 0.66-0.72, p=<0.001). Each 10-unit increase in the Life's Crucial 9 cardiovascular health score was associated with a 31% reduction in the prevalence of metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: